Safety of selamectin in cats

Veterinary Parasitology

Volumn 91, Issue 3-4, 2000, Pages 393-403

  Krautmann, M J ^a   Novotny, M J ^a   De Keulenaer, K ^b   Godin, C S ^c   Evans, E I ^d   McCall, J W ^e   Wang, C ^a   Rowan, T G ^b   Jernigan, A D ^a  

^a PFIZER INC   (United States)

^b PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United Kingdom)

^c White Eagle Toxicol Labs Inc   (United States)

^d MIDWEST RESEARCH INSTITUTE   (United States)

^e UNIVERSITY OF GEORGIA   (United States)

Author keywords

Avermectin; Cat; Safety; Selamectin; Toxicology

Indexed keywords

AVERMECTIN; SELAMECTIN; UNCLASSIFIED DRUG;

ARTICLE; CAT; DIROFILARIA IMMITIS; DRUG SAFETY; INFESTATION; NONHUMAN; PARASITE CONTROL; REPRODUCTION;

ADMINISTRATION, ORAL; ANIMALS; ANTHELMINTICS; ANTIPARASITIC AGENTS; CATS; DIROFILARIASIS; DOG DISEASES; DOGS; DOSE-RESPONSE RELATIONSHIP, DRUG; ECTOPARASITIC INFESTATIONS; FEMALE; FETUS; IVERMECTIN; MALE; PREGNANCY; REPRODUCTION;

EID: 0034705878     PISSN: 03044017     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-4017(00)00307-1     Document Type: Article

References (22)

1. 1a. Eur. J. Pharmacol. 99:1984a;269-277.
2. Drexler G., Sieghart W. Evidence for association of a high affinity avermectin binding site with benzodiazepine receptor. Eur. J. Pharmacol. 101:1984b;201-207.
3. Drexler G., Sieghart W. Sulfur-35-labeled tert-butyl-bicyclophosphorothionate and avermectin bind to different sites associated with the γ-aminobutyric acid-benzodiazepine receptor complex. Neurosci. Lett. 50:1984;273-277.
4. Duce I.R., Scott R.H. GABA sensitivity in the distal bundles of the locust extensor tibiae muscle. J. Physiol. 343:1983;32.
5. 1a on insect muscle. Br. J. Pharmacol. 85:1985;395-401.
6. Jackson, R.F., Otto, G.F., 1975. Detection and differentiation of microfilariae. In: Morgan, H.E., Otto, G.F. (Eds.), Proceedings of the Heartworm Symposium '74. VM Publishing Inc., Bonner Springs, KS, pp. 21-22.
7. Jacque C.M. La proteine gliofibrillaire acide (The glial fibrillary acidic protein). Presse Med. (France). 20:1991;1384-1390.
8. Lankas G.R., Minsker D.H., Robertson R.T. Effects of ivermectin on reproduction and neonatal toxicity in rats. Food Chem. Toxicol. 27:1989;523-529.
9. NIH, 1985. Guide for the Care and Use of Laboratory Animals, rev. 1985. Animal Welfare Act (Public Law 89-544 and all subsequent amendments). National Institutes of Health Bethesda, MD.
10. Paul A.J., Tranquilli W.J., Seward R.L., Todd K.S. Jr., Di Pietro J.A. Clinical observations in collies given ivermectin orally. Am. J. Vet. Res. 48:1987;684-685.
11. Rawlings C.A., McCall J.W. Surgical transplantation of adult Dirofilaria immitis to study heartworm infection and disease in dogs. Am. J. Vet. Res. 46:1985;221-224.
12. Rose J.M., Peckham S.L., Scism J.L., Audus K.L. Evaluation of the role of P-glycoprotein in ivermectin uptake by primary cultures of bovine brain microvessel endothelial cells. Neurochem. Res. 23:1998;203-209.
13. Schaeffer J.M., Haines H.W. Avermectin binding in Caenorhabditis elegans: a two-state model for the avermectin binding site. Biochem. Pharmacol. 38:1989;2339-2349.
14. Schiffer D., Giordana M.T., Cavalla P., Vigliani M.C., Attanasio A. Immunohistochemistry of glial reaction after injury in the rat: double stainings and markers of cell proliferation. Int. J. Dev. Neurosci. 11:1993;269-280.
15. Schinkel A.H., Smit J.J.M., van Tellingen O., Beijnen J.H., Wagenaar E., van Deemter L., Mol C.A.A.M., van der Valk M.A., Robanus-Mandaag E.C., te Riele H.P.J., Berns A.J.M., Borst P. Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs. Cell. 77:1994;491-502.
16. Schinkel A.H., Wagenaar E., Mol C.A., van Deemter L. P-glycoprotein in the blood-brain barrier of mice influences the brain penetration and pharmacological activity of many drugs. J. Clin. Invest. 97:1996;2517-2524.
17. Six R.H., Clemence R.G., Thomas C.A., Behan S., Boy M.G., Watson P., Benchaoui H.A., Clements P.J.M., Rowan T.G., Jernigan A.D. Efficacy and safety of selamectin against Sarcoptes scabiei on dogs and Otodectes cynotis on dogs and cats presented as veterinary patients. Vet. Parasitol. 91:2000;291-309.
18. Six R.H., Sture G.H., Thomas C.A., Clemence R.G., Benchaoui H.A., Boy M.G., Watson P., Smith D.G., Jernigan A.D., Rowan T.G. Efficacy and safety of selamectin against gastrointestinal nematodes in cats presented as veterinary patients. Vet. Parasitol. 91:2000;321-331.
19. Snedecor, G.W., Cochran, W.G., 1980. Failures in the assumptions. In: Statistical Methods, 7th Edition. The Iowa State University Press, Ames, IA, pp. 274-297 (Chapter 15).
20. Tranquilli W.J., Paul A.J., Todd K.S. Assessment of toxicosis induced by high-dose administration of milbemycin oxime in collies. Am. J. Vet. Res. 52:1991;1170-1172.
21. Vassilatis D.K., Arena J.P., Plasterk R.H., Wilkinson H.A., Schaeffer J.M., Cully D.F., Van der Ploeg L.H. Genetic and biochemical evidence for a novel avermectin-sensitive chloride channel in Caenorhabditis elegans. Isolation and characterization. J. Biol. Chem. 272:1997;33167-33174.
22. Wilson, J.G., Kalter, H., Palmer, A.K., Hoar, R.M., Shenefelt, R.E., Beck, F., Earl, F.L., Nelson, N.S., Berman, E., Stara, J.F., Selby, L.A., Scott Jr., W.J., 1978. Developmental abnormalities. In: Benirschke, K., Garner, F.M., Jones, T.C. (Eds.), Pathology of Laboratory Animals, Vol. 2. Springer, Berlin, pp. 1817-1946.